GPI-0100

BIOLOGICAL4 trials

Sponsors

Memorial Sloan Kettering Cancer Center, Endocyte, THEVAX Genetics Vaccine

Conditions

CancerHigh-Grade Squamous Intraepithelial LesionsHuman PapillomavirusProstate CancerRenal Cell Carcinoma

Phase 1

Vaccine Therapy Plus Biological Therapy in Treating Patients With Prostate Cancer

CompletedNCT00016146

Memorial Sloan Kettering Cancer CenterProstate Cancer

Start: 2000-07-31End: 2009-03-31Updated: 2013-03-19

Safety and Tolerability Study of FolateImmune in Combination With Cytokines in Patients With Refractory or Metastatic Cancer

CompletedNCT00329368

Start: 2005-09-30End: 2008-06-30Updated: 2012-03-09

Phase 2

A Phase II Study of EC17 (Folate-hapten Conjugate) in Patients With Progressive Metastatic Renal Cell Carcinoma

TerminatedNCT00485563

EndocyteRenal Cell Carcinoma

Start: 2007-06-30End: 2009-03-31Updated: 2012-03-08

Safety and Efficacy Study of TVGV-1 Vaccine to Treat HPV Induced Cervical HSIL

THEVAX Genetics VaccineHigh-Grade Squamous Intraepithelial Lesions, Human Papillomavirus

Start: 2015-11-30End: 2018-09-30Updated: 2017-10-25